NULL pointer dereference in Abbott Merlin\@home Ex1100
CVE-2017-5149
An issue was discovered in St. Jude Medical Merlin@home, versions prior to Version 8.2.2 (RF models: EX1150; Inductive models: EX1100; and Inductive models: EX1100 with MerlinOnDemand capability). The identities of the endpoints for the communication channel between the transmitter and St. Jude Medical's web site, Merlin.net, are not verified. This may allow a man-in-the-middle attacker to access or influence communications between the identified endpoints.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.9 (High). Vector: CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:L/I:H/A:H.
EPSS exploit prediction
EPSS: 0.012 (68.0th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 68th percentile — 68.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.012 · newest: 0.012 · change: 0.000
Affected products
- Abbott Merlin\@home Ex1100
- Abbott Merlin\@home Ex1150
- Abbott Merlin\@home Firmware
- St. Jude Merlin@home Transmitter Before 8.2.2 — versions St. Jude Merlin@home Transmitter before 8.2.2
Weakness classification (CWE)
References
- www.securityfocus.com/bid/95331 (VDB Entry, Third Party Advisory, vdb-entry)
- ics-cert.us-cert.gov/advisories/ICSMA-17-009-01A (US Government Resource, Third Party Advisory, Mitigation)
Frequently asked questions
- What is CVE-2017-5149?
- CVE-2017-5149 is a high-severity vulnerability in Abbott Merlin\@home Ex1100, classified under NULL Pointer Dereference. CVSS score: 8.9/10. Published 2017-02-13.
- How severe is CVE-2017-5149?
- High severity. CVSS v3 base score is 8.9 out of 10.